EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).

Supporters of EVISA includes:

Arzneimittel Forschung - Drug Research


changed title
ADONIS · BIOSIS Data Base · BIOTEC · Cancernet · Chemical Abstracts Service (CAS) · Current contents (Life Sciences) · Elsevier BIOBASE/Current Awareness in Biological Sciences · EMBASE/Excerpta Medica · Index Internacional de Cardiologia · Infotrieve · International Pharmaceutical Abstracts (IPA) · ISI Electronic Library · Journal of the American Medical Association (JAMA) · MEDLINE Database · Physiotherapy Evidence Database (PEDro) · Reference Update (RIS) · Science Citation Index (SCI) · SCISEARCH · University Microfilms, Inc. (UMI) · Unlisted Drugs · World Drug Alerts
Drug Research

Source type
First volume
Last volume
This journal presents the results of research in novel drug molecules and the evaluationof new drugs in development. In addition, the latest scientific findingson substances and products already marketed are discussed. Original papers from universities, the industry, private institutions, and other organisations report about new investigations carried out in the following areas of drug research and development: chemistry, synthesis, analytics, biochemistry, experimental pharmacology, toxicology, teratology, pharmacokinetics, pharmacodynamics, clinical pharmacology, efficacy testing, drug interactions, bioavailability, bioequivalence and questions relating to drug formulation, mathematical and statistical methods for the evaluation of results from industrial investigations as well as clinical trials. In the journal's special section "Biotechnology in Drug Research" investigators present their studies, results, and experience with therapeutics of biotechnological origin. Like with classical drugs, themes cover all the steps from discovery and development up to clinical research. Arzneimittel-Forschung / Drug Research publishes original papers in German or English; due to the journal's international distribution, the publishers recommend the use of English. Summaries (abstracts) of papers always appear in both languages.

Related links:

Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )